Abstract
The first syntheses of 4-epi-parviflorons A, C, and E (4-epi-1–3) were achieved in 12–13 steps from commercially available (−)-abietic acid (5). All synthesized compounds, including intermediates and derivatives, were evaluated for antiproliferative activity against five human tumor cell lines. A structure-activity relationship study revealed the importance of two oxygen functional groups at C-11 and C-12 for cytotoxic activity, as well as a combination of carbomethoxy at C4 and a benzoyl ester with electron-drawing group at C-12 or hydroxymethyl at C4 and an appropriate oxidation stage of ring-B/C for triple-negative breast cancer cell selectivity.
Funding Information
  • Eshelman Institute for Innovation, University of North Carolina
  • Ministry of Education, Culture, Sports, Science and Technology (18H02583, 25293024)

This publication has 14 references indexed in Scilit: